Suppr超能文献

乳酸杆菌作为活疫苗递送载体:进展与前景

Lactobacilli as live vaccine delivery vectors: progress and prospects.

作者信息

Seegers Jos F M L

机构信息

Lactrys, TNO Prevention and Health, Division of Immunological and Infectious Diseases, PO Box 2301 CE, Leiden, The Netherlands.

出版信息

Trends Biotechnol. 2002 Dec;20(12):508-15. doi: 10.1016/s0167-7799(02)02075-9.

Abstract

Evidence is accumulating that lactobacilli influence the immune response in a strain-dependent manner. This immunomodulatory capacity is important for the development of the immune response, and also identifies Lactobacillus as a potent oral vaccine carrier. Most of our current knowledge of the use of lactobacilli for vaccination purposes has been obtained with tetanus toxin fragment C (TTFC) as the model antigen. This knowledge, together with our ever-increasing understanding of the immune system and recent developments in cloning and expression techniques, should enable the utilisation of antigens other than TTFC and has made the development of lactobacilli as live vaccines a realistic prospect.

摘要

越来越多的证据表明,乳酸杆菌以菌株依赖的方式影响免疫反应。这种免疫调节能力对免疫反应的发展很重要,也将乳酸杆菌确定为一种有效的口服疫苗载体。我们目前关于将乳酸杆菌用于疫苗接种目的的大多数知识都是以破伤风毒素片段C(TTFC)作为模型抗原获得的。这些知识,连同我们对免疫系统不断加深的理解以及克隆和表达技术的最新进展,应该能够利用TTFC以外的抗原,并使乳酸杆菌作为活疫苗的开发成为一个现实的前景。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验